Scoping insight on antiviral drugs against COVID-19

BACKGROUND: COVID-19 is an ongoing viral pandemic produced by SARS-CoV-2. In light of in vitro efficacy, several medications were repurposed for its management. During clinical use, many of these medications produced inconsistent results or had varying limitations. OBJECTIVE: The purpose of this lit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ahmed S., Ibrahim, Ibrahim M., Burzangi, Abdulhadi S., Ghoneim, Ragia H., Aljohani, Hanin S., Alsamhan, Hamoud A., Barakat, Jehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. on behalf of King Saud University. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366046/
https://www.ncbi.nlm.nih.gov/pubmed/34909060
http://dx.doi.org/10.1016/j.arabjc.2021.103385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366046/
https://www.ncbi.nlm.nih.gov/pubmed/34909060
http://dx.doi.org/10.1016/j.arabjc.2021.103385

Ejemplares similares